---
$id: https://graph.org.ai/products/commodity/51282304
$type: Product
source: UNSPSC
code: "51282304"
title: "Erythromycin"
class: "51282300"
classTitle: "Erythromycins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Erythromycin

**UNSPSC Code**: 51282304
**Class**: [Erythromycins](Erythromycins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic with the molecular formula C37H67NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 63937KV33D, chemically known as sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin but generally known as erythromycin, which bears US NIH Compound Identifier 3255. European Medicines Agency schedules Erythromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06605MIG. The term ERYTHROMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules erythromycin in its Anatomical Therapeutic Chemical (ATC) Classification. ERYTHROMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule erythromycin under HS 29415000 and SITC 54139. As of Q4 2014, ERYTHROMYCIN remains the US FDA Preferred Term for this commodity. Erythromycin bears US NLM identifiers UMLS ID C0014806 and NCI Concept Code C476. SMILES: O(C1C(C(OC2OC(C(O)C(OC)(C2)C)C)C(C(=O)OC(C(O)(C(O)C(C(=O)C(CC1(O)C)C)C)C)CC)C)C)C1OC(CC(N(C)C)C1O)C.

